$CLDX
Celldex Therapeutics, Inc.

2012 Q1 Form 10-Q Financial Statement

#000110465912032960 Filed on May 04, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q1
Revenue $2.433M $2.516M
YoY Change -3.3% -32.18%
Cost Of Revenue $2.340M $2.500M
YoY Change -6.4% 7.3%
Gross Profit $90.00K $10.00K
YoY Change 800.0% -99.28%
Gross Profit Margin 3.7% 0.4%
Selling, General & Admin $2.320M $2.390M
YoY Change -2.93% -15.85%
% of Gross Profit 2577.78% 23900.0%
Research & Development $10.77M $6.853M
YoY Change 57.14% 6.41%
% of Gross Profit 11965.56% 68530.0%
Depreciation & Amortization $544.0K $562.0K
YoY Change -3.2% -76.87%
% of Gross Profit 604.44% 5620.0%
Operating Expenses $10.77M $6.853M
YoY Change 57.14% -36.49%
Operating Profit -$13.29M -$9.658M
YoY Change 37.59% 2.74%
Interest Expense $433.0K $485.0K
YoY Change -10.72% -82.86%
% of Operating Profit
Other Income/Expense, Net $84.00K
YoY Change
Pretax Income -$13.52M -$10.06M
YoY Change 34.39% 52.89%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$13.52M -$10.06M
YoY Change 34.39% 52.89%
Net Earnings / Revenue -555.69% -399.84%
Basic Earnings Per Share
Diluted Earnings Per Share -$4.048M -$4.701M
COMMON SHARES
Basic Shares Outstanding 57.16M shares 32.05M shares
Diluted Shares Outstanding 32.05M shares

Balance Sheet

Concept 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $92.10M $44.30M
YoY Change 107.9% -41.25%
Cash & Equivalents $22.76M $10.14M
Short-Term Investments $69.40M $34.20M
Other Short-Term Assets $2.000M $1.700M
YoY Change 17.65% -19.05%
Inventory
Prepaid Expenses
Receivables $100.0K $200.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $94.24M $46.20M
YoY Change 103.97% -41.0%
LONG-TERM ASSETS
Property, Plant & Equipment $8.400M $10.50M
YoY Change -20.0% -4.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $500.0K $400.0K
YoY Change 25.0% -93.1%
Total Long-Term Assets $42.50M $46.20M
YoY Change -8.0% -14.6%
TOTAL ASSETS
Total Short-Term Assets $94.24M $46.20M
Total Long-Term Assets $42.50M $46.20M
Total Assets $136.7M $92.40M
YoY Change 47.99% -30.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $700.0K
YoY Change -28.57% -56.25%
Accrued Expenses $6.400M $4.200M
YoY Change 52.38% 10.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $5.300M $3.300M
YoY Change 60.61% -72.27%
Total Short-Term Liabilities $12.50M $8.900M
YoY Change 40.45% -64.11%
LONG-TERM LIABILITIES
Long-Term Debt $9.900M $11.70M
YoY Change -15.38%
Other Long-Term Liabilities $6.400M $6.000M
YoY Change 6.67% -84.69%
Total Long-Term Liabilities $16.30M $17.70M
YoY Change -7.91% -54.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.50M $8.900M
Total Long-Term Liabilities $16.30M $17.70M
Total Liabilities $28.85M $26.60M
YoY Change 8.47% -58.44%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $107.9M $65.80M
YoY Change
Total Liabilities & Shareholders Equity $136.7M $92.40M
YoY Change 47.99% -30.21%

Cashflow Statement

Concept 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income -$13.52M -$10.06M
YoY Change 34.39% 52.89%
Depreciation, Depletion And Amortization $544.0K $562.0K
YoY Change -3.2% -76.87%
Cash From Operating Activities -$13.55M -$8.860M
YoY Change 52.93% 27.67%
INVESTING ACTIVITIES
Capital Expenditures $42.00K $202.0K
YoY Change -79.21% -153.16%
Acquisitions
YoY Change
Other Investing Activities -$27.47M $5.470M
YoY Change -602.19% -176.5%
Cash From Investing Activities -$27.51M $5.270M
YoY Change -622.01% -169.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $51.93M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 51.91M -7.550M
YoY Change -787.55% -5492.86%
NET CHANGE
Cash From Operating Activities -13.55M -8.860M
Cash From Investing Activities -27.51M 5.270M
Cash From Financing Activities 51.91M -7.550M
Net Change In Cash 10.85M -11.14M
YoY Change -197.4% -22.32%
FREE CASH FLOW
Cash From Operating Activities -$13.55M -$8.860M
Capital Expenditures $42.00K $202.0K
Free Cash Flow -$13.59M -$9.062M
YoY Change 49.99% 38.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q1 us-gaap Costs And Expenses
CostsAndExpenses
12174000 USD
CY2011Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
483000 USD
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2336000 USD
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6853000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13516000 USD
CY2012Q1 us-gaap Revenues
Revenues
2433000 USD
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32047000 shares
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32047000 shares
CY2011Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
46000 USD
CY2011Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
12503000 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5000000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5270000 USD
CY2011Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
64000 USD
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
202000 USD
CY2011Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3245000 USD
CY2011Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
8653000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8864000 USD
CY2011Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
288000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-929000 USD
CY2011Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10059000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-205006000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2652000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
94236000 USD
CY2011Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
170000 USD
CY2011Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
41413000 USD
CY2012Q1 us-gaap Assets
Assets
136740000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
271032000 USD
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44210636 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44210636 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
297000000 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
44000 USD
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58735636 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58735636 shares
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
297000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Liabilities
Liabilities
29272000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5966000 USD
CY2011Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
9008000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14298000 USD
CY2011Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
6136000 USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
219000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7008000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
935000 USD
CY2011Q4 us-gaap Assets
Assets
97994000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
8965000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
329000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24923000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9093000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
54684000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1202000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136740000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
107886000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
28854000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11899000 USD
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97994000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13406000 USD
CY2011Q1 us-gaap Interest Expense
InterestExpense
485000 USD
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
84000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9658000 USD
CY2011Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
37000 USD
CY2011Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
162000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-81000 USD
CY2011Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
135000 USD
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
580000 USD
CY2011Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
55000 USD
CY2011Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-5000 USD
CY2011Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-244000 USD
CY2011Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
562000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
51914000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-27507000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13553000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10140000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21287000 USD
CY2011Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-4000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-7549000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
10856000 USD

Files In Submission

Name View Source Status
0001104659-12-032960-index-headers.html Edgar Link pending
0001104659-12-032960-index.html Edgar Link pending
0001104659-12-032960.txt Edgar Link pending
0001104659-12-032960-xbrl.zip Edgar Link pending
a12-8730_110q.htm Edgar Link pending
a12-8730_1ex31d1.htm Edgar Link pending
a12-8730_1ex31d2.htm Edgar Link pending
a12-8730_1ex32d1.htm Edgar Link pending
cldx-20120331.xml Edgar Link completed
cldx-20120331.xsd Edgar Link pending
cldx-20120331_cal.xml Edgar Link unprocessable
cldx-20120331_def.xml Edgar Link unprocessable
cldx-20120331_lab.xml Edgar Link unprocessable
cldx-20120331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending